Valhalla Insights -- Emerging Issues Update: Pharmacy Benefits Outlook and Nascent GLP-1 Therapies

Description

We invite you to join business leaders, HR professionals, and healthcare decision-makers for a timely discussion on pharmacy benefits and how current trends—particularly surrounding GLP-1 therapies—are reshaping benefit plan design and spend management. On June 27, we will host our next Valhalla Insights event at the Penn Stater, where we’ll explore the broader pharmacy benefit landscape. Building on prior sessions, this conversation will expand beyond GLP-1s to cover structural and financial considerations in pharmacy plan management. Topics for discussion will include: ● The evolving impact of GLP-1 therapies on plan cost and utilization ● Market dynamics, pricing transparency, and PBM business models ● Key metrics for plan sponsors to watch and why they matter ● Rebate structures, clinical guidelines, and formulary design strategies ● Trends in specialty drug approvals and long-term planning implications Please RSVP to tim@valhallaba.com to reserve your seat. If you would like to provide feedback on the agenda or suggest focus areas, feel free to reach out to Jens, Stuart, or Mark. We believe pharmacy benefits remain one of the most consequential—and actionable—areas for improving care quality, managing costs, and fostering innovation within employer-sponsored plans. We look forward to continuing this conversation on June 27.